Emergent BioSolutions, Inc. (EBS)
5.17
+0.09
(+1.77%)
USD |
NYSE |
Aug 24, 16:00
5.17
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Price : 5.17 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 4.79 | 5.105 | 4.75 | 5.08 | 1.419M |
| Aug 20, 2026 | 4.88 | 4.935 | 4.58 | 4.82 | 1.509M |
| Aug 19, 2026 | 4.81 | 4.92 | 4.735 | 4.89 | 1.593M |
| Aug 18, 2026 | 4.46 | 4.67 | 4.46 | 4.66 | 746279.0 |
| Aug 17, 2026 | 4.50 | 4.58 | 4.43 | 4.50 | 695643.0 |
| Aug 14, 2026 | 4.50 | 4.67 | 4.45 | 4.59 | 1.095M |
| Aug 13, 2026 | 4.52 | 4.73 | 4.45 | 4.49 | 1.461M |
| Aug 12, 2026 | 4.42 | 4.64 | 4.38 | 4.55 | 1.698M |
| Aug 11, 2026 | 4.47 | 4.53 | 4.370 | 4.45 | 1.755M |
| Aug 10, 2026 | 4.72 | 4.72 | 4.36 | 4.47 | 4.333M |
| Aug 07, 2026 | 5.40 | 5.55 | 4.81 | 4.84 | 3.141M |
| Aug 06, 2026 | 5.95 | 5.97 | 5.06 | 5.31 | 4.259M |
| Aug 05, 2026 | 7.64 | 7.70 | 7.52 | 7.54 | 729016.0 |
| Aug 04, 2026 | 7.46 | 7.63 | 7.35 | 7.57 | 489104.0 |
| Aug 03, 2026 | 7.38 | 7.415 | 7.20 | 7.41 | 441012.0 |
| Jul 31, 2026 | 7.28 | 7.32 | 7.05 | 7.22 | 487190.0 |
| Jul 30, 2026 | 7.32 | 7.45 | 7.19 | 7.26 | 472188.0 |
| Jul 29, 2026 | 7.25 | 7.455 | 7.19 | 7.35 | 572661.0 |
| Jul 28, 2026 | 7.34 | 7.43 | 7.21 | 7.31 | 576060.0 |
| Jul 27, 2026 | 7.36 | 7.50 | 7.293 | 7.33 | 634629.0 |
| Jul 24, 2026 | 7.51 | 7.65 | 7.235 | 7.26 | 554005.0 |
| Jul 23, 2026 | 7.50 | 7.60 | 7.46 | 7.50 | 661151.0 |
| Jul 22, 2026 | 7.65 | 7.73 | 7.56 | 7.58 | 389703.0 |
| Jul 21, 2026 | 7.62 | 7.67 | 7.56 | 7.65 | 440792.0 |
| Jul 20, 2026 | 7.57 | 7.71 | 7.49 | 7.69 | 579485.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exelixis, Inc. | 54.57 |
| Capricor Therapeutics, Inc. | 6.81 |
| ADMA Biologics, Inc. | 9.545 |
| Akebia Therapeutics, Inc. | 0.9001 |
| Arcutis Biotherapeutics, Inc. | 24.79 |
Price Related Metrics
| PS Ratio | 0.3641 |
| Price to Book Value | 0.7768 |
| Price to Free Cash Flow | 3.265 |
| Earnings Yield | -68.74% |
| Market Cap | 265.22M |
| Operating PE Ratio | 2.049 |